TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

Eczema Clinical Trial Pipeline Accelerates as 100+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Delveinsight
Eczema Clinical Trial Pipeline Accelerates as 100+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight

Over 100 pharmaceutical companies are actively developing new drugs for eczema treatment, with approximately 10+ drugs in late-stage clinical trials and 50+ in mid and early development stages, focusing on innovative therapies targeting immune mechanisms.

Insights
JPMpL   positive

Mentioned as a source of market analysis and providing historical data about market performance after rate cuts


SNY   positive

Announced positive Phase III study results for Amlitelimab, demonstrating significant skin clearance and disease severity improvement